EMA closed 29-30 May
EMA closed 29-30 May
EMA closed 29-30 May
Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Date of authorisation: 27/09/2013, Revision: 13, Status: Authorised
Start of procedure - extension of marketing authorisation (26 April - 22 May 2025)
Start of procedure: Type II variation - extension of indication (26 April - 22 May 2025)
Minutes of the CHMP meeting 9-12 December 2024
Overview of (invented) names reviewed in April 2025 by the Name Review Group (NRG) adopted at the CHMP meeting of 22 May 2025
CTIS newsflash - 27 May 2025
List of centrally authorised products with safety-related changes to the product information
Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025
EMEA-003306-PIP01-22